| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0006700 | Intron-Exon-Intron | chr7:122047594-122127837 | chr7:122407540-122487783 | 250 nt | 0.3280 |
| hsa_CADPS2_0007300 | Exon-Exon | chr7:122047594-122131474 | chr7:122407540-122491420 | 202 nt | 0.4257 |
| hsa_CADPS2_0007400 | Exon-Exon | chr7:122047594-122194743 | chr7:122407540-122554689 | 207 nt | 0.3816 |
| hsa_CADPS2_0007500 | Exon-Exon | chr7:122047594-122221344 | chr7:122407540-122581290 | 118 nt | 0.5085 |
| hsa_CADPS2_0007600 | Intron-Exon-Intron | chr7:122051519-122058054 | chr7:122411465-122418000 | 250 nt | 0.3760 |
| hsa_CADPS2_0007800 | Exon-Exon | chr7:122056115-122091529 | chr7:122416061-122451475 | 249 nt | 0.4378 |
| hsa_CADPS2_0007900 | Exon-Exon | chr7:122056115-122130335 | chr7:122416061-122490281 | 950 nt | 0.4326 |
| hsa_CADPS2_0008000 | Exon-Exon | chr7:122056115-122153369 | chr7:122416061-122513315 | 109 nt | 0.4128 |
| hsa_CADPS2_0008100 | Intron-Exon-Intron | chr7:122069672-122091529 | chr7:122429618-122451475 | 250 nt | 0.2880 |
| hsa_CADPS2_0008200 | Intron-Intron | chr7:122070059-122070572 | chr7:122430005-122430518 | 514 nt | 0.3988 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].